Clarivate Plc

NYSE:CLVT

4.75 (USD) • At close November 13, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12001 Q2
Revenue 622.2650.3621.2683.7647.2668.8629.1668.8629.1686.6662.2560.702442.117445.645428.43455.595284.36273.5240.592255.013242.998242.309234.025245.247242.897243.297237.027686.6
Cost of Revenue 210.1398217.8412.4220.6224.2229.7224.2229.7244.1249.2187.793141.111136.607138.741130.50891.80590.85982.39982.4987.11787.62989.26795.29493.993102.042105.17244.1
Gross Profit 412.1252.3403.4271.3426.6444.6399.4444.6399.4442.5413372.909301.006309.038289.689325.087192.555182.641158.193172.523155.881154.68144.758149.953148.904141.255131.857442.5
Gross Profit Ratio 0.6620.3880.6490.3970.6590.6650.6350.6650.6350.6440.6240.6650.6810.6930.6760.7140.6770.6680.6580.6770.6410.6380.6190.6110.6130.5810.5560.644
Reseach & Development Expenses 0000000000000000000000000000
General & Administrative Expenses 000000000000000185.50998.11595.338104.41792.617105.584126.38595.47291.81896.53195.23600
Selling & Marketing Expenses 0000000000000000000000000000
SG&A 169.7185.2191.9180.4171.9192.9194.8192.9194.8186.1193.7184.142141.219149.814111.345185.50998.11595.338104.41792.617105.584126.38595.47291.81896.53195.23699.507186.1
Other Expenses 220.7491.5206.51,059.9167.50150340140.6170.2183.1176.376135.521129.444147.884137.15568.75247.36445.40953.60641.8836.45663.77452.7357.92862.0180414.3
Operating Expenses 390.4185.2372.9180.4352.7385.5335.4385.5335.4360.6376.8337.21276.74279.258259.229274.753166.867142.702149.826146.223147.464162.841159.246144.548154.459157.254177.749600.4
Operating Income 21.767.1590.987.2-88.354.6-88.354.686.244.931.9259.072-11.752-34.20729.531-12.66414.246-28.308-16.43135.844-36.581-25.919-6.455-18.931-34.43-25.8286.2
Operating Income Ratio 0.0350.1030.0080.1330.135-0.1320.087-0.1320.0870.1260.0680.0570.021-0.026-0.080.065-0.0450.052-0.118-0.0640.148-0.151-0.111-0.026-0.078-0.142-0.1090.126
Total Other Income Expenses Net -72.2-71.1-65-73.7-59.3-70.1-74.7-72.9-18.2-13.340.9-61.20312.491-7.542-21.493-89.184-20.244-21.122-30.94-63.751-23.369-37.468-33.101-34.951-32.552-32.503-50.871-13.3
Income Before Tax -50.5-311.1-60-861.927.9-158.4-20.1-158.4-20.172.985.8-111.29626.891-71.342-20.385-10.077-32.908-6.876-59.248-80.18212.475-74.049-59.02-41.406-51.483-66.933-76.69172.9
Income Before Tax Ratio -0.081-0.478-0.097-1.2610.043-0.237-0.032-0.237-0.0320.1060.13-0.1980.061-0.16-0.048-0.022-0.116-0.025-0.246-0.3140.051-0.306-0.252-0.169-0.212-0.275-0.3240.106
Income Tax Expense 15.1-6.815-1815.6-35.3-63.6-35.3-63.610.516.30.0583.57910.8683.569-16.4924.325-5.38514.7534.6051.6443.7120.242.0483.2440.0110.34610.5
Net Income -65.6-304.3-75-843.912.3-123.143.5-123.143.543.769.5-111.35423.312-82.21-23.9546.415-37.233-1.491-74.001-84.78710.831-77.761-59.26-43.454-54.727-66.944-77.03762.4
Net Income Ratio -0.105-0.468-0.121-1.2340.019-0.1840.069-0.1840.0690.0640.105-0.1990.053-0.184-0.0560.014-0.131-0.005-0.308-0.3320.045-0.321-0.253-0.177-0.225-0.275-0.3250.091
EPS -0.091-0.44-0.11-1.27-0.01-0.180.037-0.180.0650.060.1-0.170.037-0.14-0.040.01-0.096-0.004-0.22-0.280.04-0.29-0.19-0.14-0.18-0.22-46.840
EPS Diluted -0.091-0.44-0.11-1.27-0.01-0.180.036-0.170.0640.060.1-0.170.036-0.13-0.0390.01-0.096-0.004-0.22-0.280.03-0.29-0.19-0.14-0.18-0.22-46.840
EBITDA 198.9-68.1214.3-605.9250.792.7209.5267.6-4,152.2257.5212.6145.34228.7038.781113.359109.254-12.66478.166-28.30821.42379.7816.48232.23857.54654.92226.3612.64383.7
EBITDA Ratio 0.320.3870.3380.3970.3870.3550.3760.3550.3760.3750.3210.3230.350.3590.3780.3890.3320.3510.2490.320.1030.1440.1870.3050.2810.1840.1380.559